Rachel Damico is a Respiratory physician. OpenAlex indexes 204 publications with 3,752 citations (h-index 37).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1321 NW 14h St
Ste 204
Miami, FL 331251673
Telephone
305-243-6387Provider last certified this registry record 4 Apr 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20256 payments
- Actelion Pharmaceuticals US, Inc.Program year20252 payments
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.5%Endothelin Receptor Antagonist31.3%Ambrisentan60%Opsumit40%Part D<11 patientsAldosterone antagonist (MRA)7.7%Spironolactone100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
35.4%Phosphodiesterase 5 Inhibitor35.4%Tadalafil59%Sildenafil Citrate41%Part D≥15 patientsBlood & clotting
12.6%Prostacycline Vasodilator12.6%Tyvaso Dpi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2025–2025 per NIH RePORTER. The latest:
- Targeting Estrogenic pathways in Tregs to promote ARDS resolution - 5R01HL163881
University of Miami School of Medicine
FY2025$684,280R01HL163881
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
Genetics in Medicine
2023 - Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension
American Journal of Physiology-Lung Cellular and Molecular Physiology
2023 - Improved Survival for Patients with Systemic Sclerosis–associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry
American Journal of Respiratory and Critical Care Medicine
2022 - Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension
American Journal of Respiratory Cell and Molecular Biology
2021 - Exercise right ventricular ejection fraction predicts right ventricular contractile reserve
The Journal of Heart and Lung Transplantation
2021
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”